Literature DB >> 21451916

Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series.

R S C Lo1, R Krishnamoorthy, J G Freeman, A S Austin.   

Abstract

Ketamine is a dissociative anaesthetic agent that is still widely used in veterinary and human medicine. It is increasingly being used as a recreational hallucinogenic drug. Chronic ketamine abuse is known to account for lower urinary tract symptoms and urinary bladder dysfunction. There is now emerging evidence that ketamine misuse is also associated with abnormal liver function tests and biliary tract abnormality. We report three cases of chronic ketamine misuse in three young men who all presented with obstructive jaundice and biliary tract abnormality. We also describe the clinical features, radiological findings and potential underlying mechanisms for this new entity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451916

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  18 in total

1.  Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case report.

Authors:  Dewen Zhong; Feng Yu; Jiande Chen; Chaolu Lin; Huaijing Luo
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 2.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Multiorgan dysfunction related to chronic ketamine abuse.

Authors:  Joseph M Pappachan; Binu Raj; Sebastian Thomas; Fahmy W Hanna
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

Review 4.  Secondary Sclerosing Cholangitis: a Review of Recent Literature.

Authors:  John Brooling; Rolando Leal
Journal:  Curr Gastroenterol Rep       Date:  2017-09

Review 5.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

6.  Ketamine as a possible cause of cirrhosis in a patient with chronic pain.

Authors:  Roisin Bevan; Denis Burke
Journal:  Frontline Gastroenterol       Date:  2013-12-10

7.  Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.

Authors:  Thomas Marjot; Christiane S Eberhardt; Tobias Boettler; Luca S Belli; Marina Berenguer; Maria Buti; Rajiv Jalan; Mario U Mondelli; Richard Moreau; Daniel Shouval; Thomas Berg; Markus Cornberg
Journal:  J Hepatol       Date:  2022-07-20       Impact factor: 30.083

8.  Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome.

Authors:  Pedro David Wendel-Garcia; Rolf Erlebach; Rea Andermatt; Sascha David; Daniel Andrea Hofmaenner; Giovanni Camen; Reto Andreas Schuepbach; Christoph Jüngst; Beat Müllhaupt; Jan Bartussek; Philipp Karl Buehler
Journal:  Crit Care       Date:  2022-05-23       Impact factor: 19.334

Review 9.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

10.  Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.

Authors:  Silke Leonhardt; Wilfried Veltzke-Schlieker; Andreas Adler; Eckart Schott; Roland Hetzer; Walter Schaffartzik; Michael Tryba; Peter Neuhaus; Daniel Seehofer
Journal:  Crit Care       Date:  2015-03-31       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.